ストックスクリーナーアプリを入手
10.75
11.16%
-1.35
アフターアワーズ：
10.87
0.12
+1.12%
前日終値:
$12.10
開ける：
$11.75
24時間の取引高:
4.14M
Relative Volume:
1.90
時価総額：
$1.13B
収益：
$69.65M
当期純損益:
$-81.27M
株価収益率:
-11.83
EPS:
-0.9088
ネットキャッシュフロー:
$-79.45M
1週間 パフォーマンス:
-5.70%
1か月 パフォーマンス:
+93.35%
6か月 パフォーマンス:
+12.45%
1年 パフォーマンス:
+112.45%
1日の値動き範囲:
$10.38
$11.95
1週間の範囲:
$10.37
$12.53
52週間の値動き範囲:
$3.84
$12.53
Personalis Inc Stock (PSNL) Company Profile
Compare PSNL vs TMO, DHR, IDXX, A, WAT
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PSNL
Personalis Inc
|
10.75 | 1.27B | 69.65M | -81.27M | -79.45M | -0.9088 |
TMO
Thermo Fisher Scientific Inc
|
472.80 | 179.13B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
184.30 | 132.10B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
562.16 | 44.55B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
135.44 | 39.08B | 7.23B | 1.41B | 1.09B | 4.979 |
WAT
Waters Corp
|
365.36 | 36.96B | 3.77B | 449.25M | 240.68M | 7.8556 |
Personalis Inc Stock (PSNL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-02 | 再開されました | Morgan Stanley | Equal-Weight |
| 2025-05-15 | 開始されました | Guggenheim | Buy |
| 2025-03-17 | 開始されました | Craig Hallum | Buy |
| 2023-02-06 | アップグレード | Needham | Hold → Buy |
| 2022-01-07 | アップグレード | BofA Securities | Neutral → Buy |
| 2021-11-05 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-03 | ダウングレード | Needham | Buy → Hold |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-09-20 | 繰り返されました | Needham | Buy |
| 2021-05-06 | アップグレード | Oppenheimer | Perform → Outperform |
| 2021-01-28 | 開始されました | Truist | Buy |
| 2021-01-04 | ダウングレード | BofA Securities | Buy → Neutral |
| 2020-11-12 | 繰り返されました | Needham | Buy |
| 2020-11-06 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2020-10-19 | 開始されました | Citigroup | Buy |
| 2020-10-08 | 開始されました | BTIG Research | Buy |
| 2020-08-27 | 開始されました | H.C. Wainwright | Buy |
| 2020-08-18 | 開始されました | Needham | Buy |
| 2019-09-26 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | 開始されました | BofA/Merrill | Neutral |
| 2019-07-15 | 開始されました | Cowen | Outperform |
| 2019-07-15 | 開始されました | Morgan Stanley | Overweight |
| 2019-07-15 | 開始されました | Oppenheimer | Outperform |
すべてを表示
Personalis Inc (PSNL) 最新ニュース
Why Personalis Stock Is Rising: Medicare Covers Lung Cancer MRD Test - Stocktwits
Personalis (NASDAQ: PSNL) CFO sells 40,000 shares under 10b5-1 plan - Stock Titan
Personalis CFO Aaron Tachibana sells $480,400 in company stock - Investing.com
Aaron L. Tachibana (PSNL) exercises 40,000 options; prior 38,799 10b5-1 sale - Stock Titan
Personalis CEO Sells 100,000 Company Shares Worth $1.1 Million. What Does That Mean for Investors? - Yahoo Finance
Personalis Data Highlights Early Cancer Recurrence Detection - Clinical Lab Products
Personalis Highlights Early Colorectal Cancer Recurrence Detection and Ultrasensitive MRD Performance Across a Broad Set of Tumor Types at ASCO 2026 - BioSpace
Assessing Personalis (PSNL) Valuation After Its Strong Recent Share Price Momentum - Yahoo Finance
Personalis Insider Sold Shares Worth $449,292, According to a Recent SEC Filing - marketscreener.com
Personalis CEO Christopher M. Hall sells $1.1m in stock By Investing.com - Investing.com India
Personalis CEO Christopher M. Hall sells $1.1m in stock - Investing.com
Personalis CFO and COO Aaron Tachibana sells $449,292 in stock By Investing.com - Investing.com Australia
Personalis CFO and COO Aaron Tachibana sells $449,292 in stock - Investing.com
Personalis (NASDAQ: PSNL) CEO sells 100K shares after exercising options - Stock Titan
Personalis (PSNL) CFO sells shares via pre-set Rule 10b5-1 plan - Stock Titan
Personalis (PSNL) Is Up 34.5% After CMS Expands NeXT Personal MRD Test Medicare Coverage - simplywall.st
Personalis stock hits 52-week high at $11.51 By Investing.com - Investing.com Australia
[144] Personalis, Inc. SEC Filing - Stock Titan
Personalis, Inc. Hits Day High with 15.7% Surge in Stock Price - Markets Mojo
Personalis: Initiating Coverage Of Cancer Testing Biotech With A Buy Rating (NASDAQ:PSNL) - Seeking Alpha
ETFs Investing in Personalis, Inc. Stocks - TradingView
Personalis gains after fourth Medicare coverage win for NeXT Personal - MSN
Personalis to Highlight Breadth of NeXT Personal® Ultra-Sensitive ctDNA Data at ASCO 2026 Annual Meeting, Including Podium Presentation from TRACERx Consortium - BioSpace
Personalis Inc. (PSNL) Rallies 2.67% as Volume Picks Up – Key Levels in SightFair Value Gap - thelegaladvocate.com
Personalis Inc. (PSNL) Surges 4.5% as Stock Tests Key Resistance Near $9.05Overnight Profile - thelegaladvocate.com
Craig-Hallum Maintains Personalis(PSNL.US) With Buy Rating - Moomoo
Personalis outlines 2026 clinical volume target of 43,000 to 45,000 tests while reaffirming $78M to $80M revenue guidance - MSN
Personalis NeXT Disease Test Approved for Expanded Coverage by Medicare, Medicaid - Moomoo
Lake Street Maintains Personalis(PSNL.US) With Buy Rating, Maintains Target Price $11 - Moomoo
Medicare Expands Coverage for Personalis NeXT Personal Test - TipRanks
US agency broadens coverage of Personalis breast cancer test - MSN
Expanded Medicare covers Personalis (NASDAQ: PSNL) NeXT Personal cancer test - Stock Titan
Personalis gains expanded Medicare coverage for breast cancer test By Investing.com - Investing.com Nigeria
US Agency Broadens Coverage Of Personalis Breast Cancer Test - Benzinga
Personalis Shares Rise After NeXT Disease Test Approved for Expanded Coverage by Medicare, Medicaid - marketscreener.com
Personalis (PSNL) Shares Climb on Expanded Medicare Coverage for NeXT Personal Test - GuruFocus
Personalis (PSNL) Expands Medicare Coverage for NeXT Personal Te - GuruFocus
Personalis gets expanded Medicare coverage for NeXT Personal - Seeking Alpha
Personalis secures fourth Medicare coverage decision for Next Personal, expanding breast cancer coverage to pre-surgical treatment monitoring - marketscreener.com
Personalis gains expanded Medicare coverage for breast cancer test - Investing.com
Personalis Secures Fourth Medicare Coverage Decision for NeXT Personal®, Expanding Breast Cancer Coverage to Pre-Surgical Treatment Monitoring - Business Wire
Personalis rises as Medicare coverage for NeXT Personal test expands - MSN
Personalis Inc (PSNL) 財務データ
収益
当期純利益
現金流量
EPS
2.13%
2.22%
大文字化:
|
ボリューム (24 時間):